Skip to the video

Glioblastoma: Year of the Zebra

Series destacadasAño de la Cebra (enfermedades raras)Sistema neurológico
Encuentros con pacientesFuentesMy Notes

Encuentros con pacientes

en inglés

Glioblastoma Brain Cancer Story of Police Officer Ryan Masales

Glioblastoma Brain Cancer Story of Police Officer Ryan Masales

DUPLICATE

Year of the Zebra

I Know a Zebra - Glioblastoma

I Know a Zebra - Glioblastoma

Most of us live our lives according to our plans and expectations. We have small goals for the day, overarching targets for the year, expectations for the decade, and dreams for the future. What we don’t realize is how fast things can change, and how our life plans have to sometimes adapt radically to new circumstances. This is the reality of this week’s zebra, Glioblastoma. Glioblastomas are aggressive and malignant brain tumors that originate from a type of glial cell in the brain called an astrocyte. Usually, glioblastoma growth rate is characterized as grade IV on a scale from I to IV, indicating rapid tumor growth. Glioblastomas can be located anywhere in the brain and do not regularly spread outside of the brain. Common symptoms include headaches, seizures, confusion, memory loss, muscle weakness, visual changes, language deficit and cognitive changes. The age group affected is usually older individuals aged 45 to 70 with rare occurrences in children. About 3 in every 100,000 people per year are affected by glioblastoma. Treatment methods typically include a combination of surgery, chemotherapy, radiation therapy and others. To learn more about the diagnosis and treatment of Glioblastoma, watch the dedicated Osmosis video on YouTube and Osmosis.org

Year of the Zebra

Fuentes

  1. "Treatment of Glioblastoma" Journal of Oncology Practice (2017)
  2. "A Review of Newly Diagnosed Glioblastoma" Frontiers in Oncology (2021)
  3. "Emerging therapies for glioblastoma: current state and future directions" Journal of Experimental & Clinical Cancer Research (2022)
  4. "Butterfly Glioma" New England Journal of Medicine (2018)
  5. "Management of glioblastoma: State of the art and future directions" CA: A Cancer Journal for Clinicians (2020)

Aún no hay notas para este video

Intenta agregar una nota a continuación

Ask Osmosis AI

Grounded in trusted Elsevier sources-- not the open web

Explain this simply

Get clearer explanations of difficult concepts.

Trial

Summarize high-yield points

Review what matters most for exams.

Trial

Quiz me with 3 questions

Practice active recall for exam prep after watching.

Trial

Create flashcards

Make review faster and easier.

Trial

Try the full Osmosis experience

Watch the full video

Ask Osmosis AI questions

Generate practice questions

Generate flashcards

Create a personalized study schedule

Ver paquetes

Related

Up next

Sistema neurológico

Acoustic neuroma: Year of the Zebra 2024
Alexander disease: Year of the Zebra 2025
Brown-Séquard syndrome: Year of the Zebra
Canavan disease: Year of the Zebra
Cockayne syndrome: Year of the Zebra 2026
GABA transaminase deficiency: Year of the Zebra 2026
Glioblastoma: Year of the Zebra
Huntington disease: Year of the Zebra
Idiopathic intracranial hypertension: Year of the Zebra
Infantile neuroaxonal dystrophy: Year of the Zebra
Isodicentric chromosome 15 syndrome: Year of the Zebra 2026
KIF1A-associated neurological disorder: Year of the Zebra
Multiple system atrophy (MSA): Year of the Zebra 2025
Myasthenia gravis: Year of the Zebra 2024
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Year of the Zebra 2026
Narcolepsy (NORD): Year of the Zebra
Neuroblastoma: Year of the Zebra 2024
Neuronal ceroid lipofuscinoses (Batten disease): Year of the Zebra
Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus infections (PANDAS): Year of the Zebra 2025
Spastic paraplegia type 4 (SPG4): Year of the Zebra 2025
Syringomyelia: Year of the Zebra
Thoracic outlet syndrome: Year of the Zebra
Wernicke-Korsakoff syndrome: Year of the Zebra
Osmosis from Elsevier logo

Exams

  • USMLE 1+2
  • COMLEX 1+2
  • PANCE
  • NCLEX
  • UKMLA
  • ABFM/ABIM

Pricing

  • Medicine (MD)
  • Medicine (DO)
  • Nurse Practitioner
  • Physician Assistant
  • Registered Nurse
  • Licensed Practical Nursing
  • Dentistry
  • Pharmacy
  • Health Professional

Follow us

  • YouTube
  • LinkedIn
  • Facebook
  • Instagram (Medical)
  • Instagram (Nursing)
  • Bluesky
  • Twitter
  • TikTok

Empresa

  • About Us
  • Carreras
  • Prensa
  • Contáctanos

Resources

  • Biblioteca
  • Blog
  • Events
  • Podcast
  • Help Center

For institutions

  • Institutions
Elsevier

Copyright © 2026 Elsevier B.V.

Este sitio utiliza cookies.

Términos y Condiciones

|

Política de privacidad

|

Mensaje de galletas

|

Mapa del sítio

USMLE® es un programa conjunto de la Federación de Juntas Médicas Estatales (FSMB) y la Junta Nacional de Examinadores Médicos (NBME) de EE.UU. COMLEX-USA® es una marca comercial registrada de The National Board of Osteopathy Medical Examiners, Inc. NCLEX-RN® es una marca comercial registrada de National Council of State Boards of Nursing, Inc. Los nombres de las pruebas y otras marcas comerciales son propiedad de los respectivos titulares de marcas registradas. Ninguno de los titulares de las marcas registradas está respaldado ni afiliado a Osmosis o a este sitio web.